Sequential pulse therapy with itraconazole and terbinafine to treat onychomycosis of the fingernails

Journal of Dermatological Treatment

Volumn 11, Issue 3, 2000, Pages 151-154

  Gupta, A K ^a   Konnikov, N ^b,c   Lynde, C W ^d  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TORONTO WESTERN HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Candida species; Dermatophytes; Fingernails; Itraconazole; Onychomycosis; Pulse; Sequential; Terbinafine; Therapy

Indexed keywords

ITRACONAZOLE; TERBINAFINE;

ADULT; ARTICLE; CANDIDA; CLINICAL ARTICLE; CLINICAL TRIAL; CONVALESCENCE; DISEASE DURATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FINGER NAIL; GASTROINTESTINAL DISEASE; HEADACHE; HUMAN; MALE; MULTICENTER STUDY; ONYCHOMYCOSIS; PATIENT COMPLIANCE; PRIORITY JOURNAL; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; TRICHOPHYTON RUBRUM;

EID: 0033787066     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/09546630050517298     Document Type: Article

References (9)

1. Antifungals - An overview. Part II - CME article
2. Itraconazole intermittent pulse therapy is effective and safe in the treatment of onychomycosis and dermatomycoses: An overview
3. Biochemical approaches to selective antifungal activity. Focus on azole agents
4. Terbinafine mode of action and properties of the squalene epoxidase inhibition
5. Pharmacokinetic profile of orally administered itraconazole in human skin
6. A randomized treatment duration-finding study of terbinafine in onychomycosis
7. Evaluation of 6 weeks treatment of terbinafine in tinea unguium in a double-blind trial comparing 6 and 12 weeks therapy
8. A multicenter, placebo-controlled, double-blind study of intermittent therapy with itraconazole for the treatment of onychomycosis of the fingernail